05/02/2024 3:40 PM | Namouni Fouad (Reporting) Vor Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/02/2024 3:39 PM | Namouni Fouad (Reporting) Vor Biopharma (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
04/09/2024 3:05 PM | Vor Biopharma (Filer)
| Form DEF 14A | |
04/09/2024 3:07 PM | Vor Biopharma (Filer)
| Form DEFA14A | |
04/09/2024 3:10 PM | Vor Biopharma (Filer)
| Form ARS | |
02/08/2024 4:10 PM | Attar Eyal C. (Reporting) Vor Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/08/2024 4:05 PM | Chakraborty Tirtha (Reporting) Vor Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/08/2024 4:06 PM | Jorgensen Nathan D. (Reporting) Vor Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/08/2024 4:08 PM | ANG ROBERT (Reporting) Vor Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2024 6:38 PM | Attar Eyal C. (Reporting) Vor Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2024 6:34 PM | Jorgensen Nathan D. (Reporting) Vor Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2024 6:35 PM | ANG ROBERT (Reporting) Vor Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2024 6:36 PM | Chakraborty Tirtha (Reporting) Vor Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/05/2024 4:03 PM | Vor Biopharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/02/2023 8:10 AM | Vor Biopharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/06/2023 3:28 PM | Vor Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/06/2023 3:29 PM | Chakraborty Tirtha (Reporting) Vor Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/06/2023 3:31 PM | Jorgensen Nathan D. (Reporting) Vor Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/30/2023 3:51 PM | Vor Biopharma (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/11/2023 4:05 PM | RA CAPITAL MANAGEMENT, L.P. (Filed by) Vor Biopharma (Subject)
| Form SC 13D/A | |
06/09/2023 6:41 AM | Vor Biopharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/02/2023 5:09 PM | Kolchinsky Peter (Reporting) RA Capital Healthcare Fund LP (Reporting) RA CAPITAL MANAGEMENT, L.P. (Reporting) Shah Rajeev M. (Reporting) Vor Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/02/2023 3:33 PM | Beckman Daniella (Reporting) Vor Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |